View Financial HealthHerbal Dispatch 배당 및 자사주 매입배당 기준 점검 0/6Herbal Dispatch 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-27.1%자사주 매입 수익률총 주주 수익률-27.1%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesReported Earnings • May 31First quarter 2026 earnings released: CA$0.007 loss per share (vs CA$0.004 loss in 1Q 2025)First quarter 2026 results: CA$0.007 loss per share (further deteriorated from CA$0.004 loss in 1Q 2025). Revenue: CA$1.76m (down 35% from 1Q 2025). Net loss: CA$845.6k (loss widened 195% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Board Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). Independent Director Drew Malcolm was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • Oct 21Herbal Dispatch Inc. announced that it has received CAD 2.078211 million in fundingOn October 20, 2025, Herbal Dispatch Inc. closed the transaction. The company issued 41,564,220 units at a price of CAD 0.05 per Unit for gross proceeds of up to CAD 2,078,211. In connection with the closing of the private placement, the company incurred finder's fees to qualified arm’s length finders (the “finders”) as follows: (a) an aggregate cash payment of CAD 103,495; and (b) the issuance of 599,900 Warrants. Such finder’s fees were paid only to Finders who executed finder’s fee agreements with the Company and who successfully introduced investors that participated in the Private Placement. The transaction included participation from new investors Roderick W. Law Corporation, EPC Holdings Ltd., and ADH Holdings Ltd., for an aggregate of 6,814,420 Units, representing approximately 16.39% of the total Units permitted to be subscribed for under the Private Placement.공시 • Jul 30Herbal Dispatch Inc. announced that it expects to receive CAD 1 million in fundingHerbal Dispatch Inc. announced a non-brokered private placement of up to 20,000,000 units at a price of CAD 0.05 per Unit for gross proceeds of up to CAD 1,000,000. Each Unit shall consist of one common share and one-half common share purchase warrant with each Warrant transferable and exercisable for one common share at a price of CAD 0.08 per share for a period of 24 months after the closing date. The Private Placement shall be completed on a best-efforts basis from eligible purchasers that shall be restricted to accredited investors or other investors meeting exemption requirements for a non-brokered private placement. The closing of the Private Placement is expected to occur before August 29, 2025, and is subject to receipt of all necessary regulatory approvals, including the approval of the CSE. Should the Private Placement be oversubscribed, the Company reserves the right to accept additional funds, subject to the approval of the Canadian Securities Exchange (“CSE”). All securities issued pursuant to the Private Placement will be subject to a four month hold period in accordance with applicable Canadian securities laws.공시 • Apr 08Herbal Dispatch Inc., Annual General Meeting, Jun 10, 2025Herbal Dispatch Inc., Annual General Meeting, Jun 10, 2025.공시 • Mar 25Herbal Dispatch Inc. announced that it has received CAD 0.6 million in fundingHerbal Dispatch Inc. announced that it will receive CAD 600,000 in a round of funding on March 25, 2025. The company will also issue 3,000,000 warrants in the transaction. Each warrants are convertible to common stock of the company at an exercise price of $0.065 per share. The warrants will expire on March 19, 2029. The company has received debt in the transaction which incurs interest rate of 18% p.a. and is repayable in equal monthly instalments of $29,955. The warrants carry a hold period of four months. The company has incurred a closing fee of $12,000 in the transaction. The transaction included participation from Philip Campbell representing one of the Lenders, and via a wholly owned company, and provided $100,000 of the debt and will receive 500,100 of the warrants issued.공시 • Oct 09Herbal Dispatch Inc., Annual General Meeting, Dec 16, 2024Herbal Dispatch Inc., Annual General Meeting, Dec 16, 2024.Reported Earnings • Aug 23Second quarter 2024 earnings released: EPS: CA$0.001 (vs CA$0.006 loss in 2Q 2023)Second quarter 2024 results: EPS: CA$0.001 (up from CA$0.006 loss in 2Q 2023). Revenue: CA$3.65m (up 215% from 2Q 2023). Net income: CA$58.6k (up CA$460.2k from 2Q 2023). Profit margin: 1.6% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue.New Risk • May 30New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$472k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$472k free cash flow). Share price has been highly volatile over the past 3 months (13% average weekly change). Market cap is less than US$10m (€2.76m market cap, or US$2.98m). Minor Risks Shareholders have been diluted in the past year (11% increase in shares outstanding). Revenue is less than US$5m (CA$5.7m revenue, or US$4.2m).Board Change • May 13Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Drew Malcolm was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • May 10Herbal Dispatch Inc. Announces Board ChangesHerbal Dispatch Inc. announces that effective May 8, 2024, Jeremy South has resigned as a Director and Chairman of the Company. The Company is grateful to Mr. South for his contribution throughout the yearsand wishes him all the best in his future endeavors. The Honourable Herb Dhaliwal, a Director the Company, has agreed to be appointed as interim Chairman of the Company until a permanent successoris appointed.Reported Earnings • May 02Full year 2023 earnings released: CA$0.029 loss per share (vs CA$0.092 loss in FY 2022)Full year 2023 results: CA$0.029 loss per share (improved from CA$0.092 loss in FY 2022). Revenue: CA$4.74m (up CA$4.43m from FY 2022). Net loss: CA$2.07m (loss narrowed 55% from FY 2022).공시 • Mar 21Herbal Dispatch Inc. announced that it expects to receive CAD 1 million in fundingHerbal Dispatch Inc. announced on best-effort basis a non-brokered private placement of up to 20,000,000 units at a price of CAD 0.05 per unit for the gross proceeds of CAD 1,000,000 on March 20, 2024. Each Unit shall consist of one common share and one common share warrant with each Warrant exercisable for one common share at a price of CAD 0.06 per share for a period of 24 months after the closing date. Should the Private Placement be oversubscribed, the Company reserves the right to accept additional funds, subject to the approval of the Canadian Securities Exchange and is also subjected to regulatory approvals. The closing of the Private Placement is expected to occur before April 5, 2024. All securities issued pursuant to the private placement will be subject to a four month hold period in accordance with applicable Canadian securities laws.공시 • Dec 16Herbal Dispatch Inc. announced that it expects to receive CAD 0.938 million in fundingHerbal Dispatch Inc. announced that it has issued an unsecured convertible debenture in the principal amount of CAD 938,000 for gross proceeds of CAD 938,000 on December 15, 2023. The transaction included participation from directors. The company also amended the terms of a convertible debenture in the principal amount of CAD 438,000 owing to another director of the company. The debenture bears interest at an annual rate of 14% per annum, payable monthly, and matures on January 31, 2025. The transaction is subject to the approval of the Canadian Securities Exchange. The debenture will also be convertible, at the holder’s option into common shares of the company at a price of CAD 0.05 per share, and at the it’s election, during any period where the trading price of the it’s common shares is CAD 0.10 or greater for a period of 20 consecutive trading days. The company issued principal amount of CAD 500,000 to a director of the company in its first tranche.Reported Earnings • Nov 25Third quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.001 loss in 3Q 2022)Third quarter 2023 results: CA$0.001 loss per share (in line with 3Q 2022). Revenue: CA$1.17m (up CA$1.07m from 3Q 2022). Net loss: CA$533.0k (loss narrowed 32% from 3Q 2022).공시 • Oct 07Herbal Dispatch Inc., Annual General Meeting, Dec 15, 2023Herbal Dispatch Inc., Annual General Meeting, Dec 15, 2023.Reported Earnings • Aug 31Second quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.003 loss in 2Q 2022)Second quarter 2023 results: CA$0.001 loss per share (improved from CA$0.003 loss in 2Q 2022). Revenue: CA$1.16m (up CA$1.15m from 2Q 2022). Net loss: CA$401.7k (loss narrowed 71% from 2Q 2022).Reported Earnings • Jun 02First quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.001 loss in 1Q 2022)First quarter 2023 results: CA$0.001 loss per share (in line with 1Q 2022). Net loss: CA$685.8k (loss widened 23% from 1Q 2022).공시 • May 27Herbal Dispatch Inc. announced that it expects to receive CAD 1 million in fundingHerbal Dispatch Inc. announced a non-brokered private placement of up to 100,000,000 units at a price of CAD 0.01 per unit for the gross proceeds of CAD 1,000,000 on May 25, 2023. Each unit consist of one common share and one common share warrant. Each warrant is exercisable for one common share at a price of CAD 0.05 per share for a period of 24 months after the closing date. All securities issued pursuant to the private placement will be subject to a four month hold period. The transaction is subject to the approval of all necessary regulatory approvals including the approval of the CSE. The transaction is expected to close on June 30, 2023.Reported Earnings • May 01Full year 2022 earnings released: CA$0.009 loss per share (vs CA$0.006 loss in FY 2021)Full year 2022 results: CA$0.009 loss per share (further deteriorated from CA$0.006 loss in FY 2021). Net loss: CA$4.62m (loss widened 93% from FY 2021).Reported Earnings • Dec 02Third quarter 2022 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 3Q 2021)Third quarter 2022 results: CA$0.001 loss per share (improved from CA$0.002 loss in 3Q 2021). Net loss: CA$778.0k (loss narrowed 7.3% from 3Q 2021).지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 HA9 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: HA9 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Herbal Dispatch 배당 수익률 vs 시장HA9의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (HA9)n/a시장 하위 25% (DE)1.5%시장 상위 25% (DE)4.7%업계 평균 (Pharmaceuticals)2.8%분석가 예측 (HA9) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 HA9 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 HA9 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 HA9 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: HA9 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/08 13:12종가2026/06/08 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Herbal Dispatch Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • May 31First quarter 2026 earnings released: CA$0.007 loss per share (vs CA$0.004 loss in 1Q 2025)First quarter 2026 results: CA$0.007 loss per share (further deteriorated from CA$0.004 loss in 1Q 2025). Revenue: CA$1.76m (down 35% from 1Q 2025). Net loss: CA$845.6k (loss widened 195% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Board Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). Independent Director Drew Malcolm was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • Oct 21Herbal Dispatch Inc. announced that it has received CAD 2.078211 million in fundingOn October 20, 2025, Herbal Dispatch Inc. closed the transaction. The company issued 41,564,220 units at a price of CAD 0.05 per Unit for gross proceeds of up to CAD 2,078,211. In connection with the closing of the private placement, the company incurred finder's fees to qualified arm’s length finders (the “finders”) as follows: (a) an aggregate cash payment of CAD 103,495; and (b) the issuance of 599,900 Warrants. Such finder’s fees were paid only to Finders who executed finder’s fee agreements with the Company and who successfully introduced investors that participated in the Private Placement. The transaction included participation from new investors Roderick W. Law Corporation, EPC Holdings Ltd., and ADH Holdings Ltd., for an aggregate of 6,814,420 Units, representing approximately 16.39% of the total Units permitted to be subscribed for under the Private Placement.
공시 • Jul 30Herbal Dispatch Inc. announced that it expects to receive CAD 1 million in fundingHerbal Dispatch Inc. announced a non-brokered private placement of up to 20,000,000 units at a price of CAD 0.05 per Unit for gross proceeds of up to CAD 1,000,000. Each Unit shall consist of one common share and one-half common share purchase warrant with each Warrant transferable and exercisable for one common share at a price of CAD 0.08 per share for a period of 24 months after the closing date. The Private Placement shall be completed on a best-efforts basis from eligible purchasers that shall be restricted to accredited investors or other investors meeting exemption requirements for a non-brokered private placement. The closing of the Private Placement is expected to occur before August 29, 2025, and is subject to receipt of all necessary regulatory approvals, including the approval of the CSE. Should the Private Placement be oversubscribed, the Company reserves the right to accept additional funds, subject to the approval of the Canadian Securities Exchange (“CSE”). All securities issued pursuant to the Private Placement will be subject to a four month hold period in accordance with applicable Canadian securities laws.
공시 • Apr 08Herbal Dispatch Inc., Annual General Meeting, Jun 10, 2025Herbal Dispatch Inc., Annual General Meeting, Jun 10, 2025.
공시 • Mar 25Herbal Dispatch Inc. announced that it has received CAD 0.6 million in fundingHerbal Dispatch Inc. announced that it will receive CAD 600,000 in a round of funding on March 25, 2025. The company will also issue 3,000,000 warrants in the transaction. Each warrants are convertible to common stock of the company at an exercise price of $0.065 per share. The warrants will expire on March 19, 2029. The company has received debt in the transaction which incurs interest rate of 18% p.a. and is repayable in equal monthly instalments of $29,955. The warrants carry a hold period of four months. The company has incurred a closing fee of $12,000 in the transaction. The transaction included participation from Philip Campbell representing one of the Lenders, and via a wholly owned company, and provided $100,000 of the debt and will receive 500,100 of the warrants issued.
공시 • Oct 09Herbal Dispatch Inc., Annual General Meeting, Dec 16, 2024Herbal Dispatch Inc., Annual General Meeting, Dec 16, 2024.
Reported Earnings • Aug 23Second quarter 2024 earnings released: EPS: CA$0.001 (vs CA$0.006 loss in 2Q 2023)Second quarter 2024 results: EPS: CA$0.001 (up from CA$0.006 loss in 2Q 2023). Revenue: CA$3.65m (up 215% from 2Q 2023). Net income: CA$58.6k (up CA$460.2k from 2Q 2023). Profit margin: 1.6% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue.
New Risk • May 30New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$472k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$472k free cash flow). Share price has been highly volatile over the past 3 months (13% average weekly change). Market cap is less than US$10m (€2.76m market cap, or US$2.98m). Minor Risks Shareholders have been diluted in the past year (11% increase in shares outstanding). Revenue is less than US$5m (CA$5.7m revenue, or US$4.2m).
Board Change • May 13Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Drew Malcolm was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • May 10Herbal Dispatch Inc. Announces Board ChangesHerbal Dispatch Inc. announces that effective May 8, 2024, Jeremy South has resigned as a Director and Chairman of the Company. The Company is grateful to Mr. South for his contribution throughout the yearsand wishes him all the best in his future endeavors. The Honourable Herb Dhaliwal, a Director the Company, has agreed to be appointed as interim Chairman of the Company until a permanent successoris appointed.
Reported Earnings • May 02Full year 2023 earnings released: CA$0.029 loss per share (vs CA$0.092 loss in FY 2022)Full year 2023 results: CA$0.029 loss per share (improved from CA$0.092 loss in FY 2022). Revenue: CA$4.74m (up CA$4.43m from FY 2022). Net loss: CA$2.07m (loss narrowed 55% from FY 2022).
공시 • Mar 21Herbal Dispatch Inc. announced that it expects to receive CAD 1 million in fundingHerbal Dispatch Inc. announced on best-effort basis a non-brokered private placement of up to 20,000,000 units at a price of CAD 0.05 per unit for the gross proceeds of CAD 1,000,000 on March 20, 2024. Each Unit shall consist of one common share and one common share warrant with each Warrant exercisable for one common share at a price of CAD 0.06 per share for a period of 24 months after the closing date. Should the Private Placement be oversubscribed, the Company reserves the right to accept additional funds, subject to the approval of the Canadian Securities Exchange and is also subjected to regulatory approvals. The closing of the Private Placement is expected to occur before April 5, 2024. All securities issued pursuant to the private placement will be subject to a four month hold period in accordance with applicable Canadian securities laws.
공시 • Dec 16Herbal Dispatch Inc. announced that it expects to receive CAD 0.938 million in fundingHerbal Dispatch Inc. announced that it has issued an unsecured convertible debenture in the principal amount of CAD 938,000 for gross proceeds of CAD 938,000 on December 15, 2023. The transaction included participation from directors. The company also amended the terms of a convertible debenture in the principal amount of CAD 438,000 owing to another director of the company. The debenture bears interest at an annual rate of 14% per annum, payable monthly, and matures on January 31, 2025. The transaction is subject to the approval of the Canadian Securities Exchange. The debenture will also be convertible, at the holder’s option into common shares of the company at a price of CAD 0.05 per share, and at the it’s election, during any period where the trading price of the it’s common shares is CAD 0.10 or greater for a period of 20 consecutive trading days. The company issued principal amount of CAD 500,000 to a director of the company in its first tranche.
Reported Earnings • Nov 25Third quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.001 loss in 3Q 2022)Third quarter 2023 results: CA$0.001 loss per share (in line with 3Q 2022). Revenue: CA$1.17m (up CA$1.07m from 3Q 2022). Net loss: CA$533.0k (loss narrowed 32% from 3Q 2022).
공시 • Oct 07Herbal Dispatch Inc., Annual General Meeting, Dec 15, 2023Herbal Dispatch Inc., Annual General Meeting, Dec 15, 2023.
Reported Earnings • Aug 31Second quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.003 loss in 2Q 2022)Second quarter 2023 results: CA$0.001 loss per share (improved from CA$0.003 loss in 2Q 2022). Revenue: CA$1.16m (up CA$1.15m from 2Q 2022). Net loss: CA$401.7k (loss narrowed 71% from 2Q 2022).
Reported Earnings • Jun 02First quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.001 loss in 1Q 2022)First quarter 2023 results: CA$0.001 loss per share (in line with 1Q 2022). Net loss: CA$685.8k (loss widened 23% from 1Q 2022).
공시 • May 27Herbal Dispatch Inc. announced that it expects to receive CAD 1 million in fundingHerbal Dispatch Inc. announced a non-brokered private placement of up to 100,000,000 units at a price of CAD 0.01 per unit for the gross proceeds of CAD 1,000,000 on May 25, 2023. Each unit consist of one common share and one common share warrant. Each warrant is exercisable for one common share at a price of CAD 0.05 per share for a period of 24 months after the closing date. All securities issued pursuant to the private placement will be subject to a four month hold period. The transaction is subject to the approval of all necessary regulatory approvals including the approval of the CSE. The transaction is expected to close on June 30, 2023.
Reported Earnings • May 01Full year 2022 earnings released: CA$0.009 loss per share (vs CA$0.006 loss in FY 2021)Full year 2022 results: CA$0.009 loss per share (further deteriorated from CA$0.006 loss in FY 2021). Net loss: CA$4.62m (loss widened 93% from FY 2021).
Reported Earnings • Dec 02Third quarter 2022 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 3Q 2021)Third quarter 2022 results: CA$0.001 loss per share (improved from CA$0.002 loss in 3Q 2021). Net loss: CA$778.0k (loss narrowed 7.3% from 3Q 2021).